Journal of Bacteriology, October 1998, p. 5151-5158, Vol. 180, No. 19
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
andDepartment of Molecular and Cell Biology, University of California, Berkeley, California 94720-3202
Received 11 June 1998/Accepted 3 August 1998
| |
ABSTRACT |
|---|
|
|
|---|
The sid gene promoter (Psid),
which controls expression of the late genes from satellite phage P4, is
activated by a unique class of small DNA-binding proteins. The
activators from both satellite and helper phages stimulate
transcription from Psid. These activators bind
to sites centered at position
55 in all the helper and satellite
phage late promoters. P4 Psid is unique in that
it has an additional activator binding site centered at position
18
(site II). We have constructed a mutant of site II that no longer binds
activators. Transcription under the control of satellite phage
activators is increased by the site II mutation. In contrast, helper
phage activators do not show this increase in transcription from
Psid mutated at site II. Competition gel shift
analysis reveals that the P4 satellite phage activator, Delta, binds
eightfold better to site II than to site I. The products of the
sid transcription unit are needed only when a helper phage
is present; thus, the satellite phage activators repress transcription
until the helper is present to supply a nonrepressing activator.
| |
INTRODUCTION |
|---|
|
|
|---|
Satellite (helper-dependent) phages
P4 and
R73 require head, tail, and lysis genes from a helper phage
of the P2 family in order to produce progeny (10, 23, 26).
Both satellite phages are temperate, and each has a chromosomally
integrated prophage state (1, 10, 23, 26). P4 can also
establish a plasmid state, and clear-plaque-type mutants establish this
state at a higher frequency than does the wild type (4, 6,
20). When Escherichia coli that is lysogenic for
integrated P4 is infected with helper phage, the helper grows well and
there is little production of P4 (24). If the infecting
helper phage is blocked from replication by a mutation in its own
genome or in that of the host, then P4 progeny are produced efficiently
(24). P4 is also produced efficiently when P2 infects a
bacterium carrying the P4 plasmid (25). When P4 infects a
bacterium that is lysogenic for a helper phage, P4 grows well and
little P2 is produced. When P4 and a helper phage coinfect a
nonlysogenic strain, both phage types are produced, although P4 is
produced in greater quantity (5, 23). In order to make use
of the helper late genes, the satellite phages carry a gene for
derepression of P2 prophage (18), as well as a gene for
activation of helper phage late gene promoters (for a review, see
reference 17).
P4 and
R73 encode transcriptional activators for the expression of
the late genes of their helper phages, as well as for the expression of
their own late genes. The activators of the satellite and helper phages
are small proteins that contain the motif
CysX2CysX22CysX4Cys and contain one
atom of zinc (14, 15, 21). They bind to the consensus
sequence TGTX12ACA (21). The genes for the
satellite phage activators lie within a late transcription unit that
contains the gene for capsid size determination, sid,
followed by the activator gene,
, and the capsid stabilization gene,
psu. The promoter for this transcription unit is called Psid. Transcription from this promoter could not
be detected from the prophage, nor could it be detected in P4-infected,
nonlysogenic cells before 40 min. During P4 infection of a P2-lysogenic
strain, transcription is detected at 30 min at a high level
(3). In contrast to helper phage late promoters,
Psid is activated better by helper phage
activators than by satellite phage activators, as measured in a
two-plasmid system (13). Footprint analysis of helper and
satellite phage activators on helper and satellite phage late promoters
revealed activator binding sites centered about coordinate
55 from
the start of transcription (site I). In addition,
Psid has an activator-binding site centered at
position
18 (site II), and the satellite phage activators appear to
have higher affinities for this site than for site I (12,
13). Regulators that bind near
55 usually function to activate
transcription (7). This principle holds for
Psid, because mutations of the conserved
residues in site I abolish promoter activity (27).
Regulators that bind near
18 usually function to repress
transcription (2). Thus, we suspected that mutation of site
II of Psid would abolish a repressive effect.
Previous analysis of Psid showed that mutating the first A residue of the ACA of site II (Fig.
1) reduces promoter activity 100-fold
(27). This is not surprising, since this nucleotide, at
11, is part of the
10 region that is characteristic of E. coli sigma-70 promoters. Since previous work did not specifically target the TGT of site II for mutagenesis, we analyzed these
nucleotides and report here their contributions to the activity and
specificity of Psid.
|
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacteria, phages, and plasmid strains. Bacteria, phages, and plasmid strains are described in Table 1.
|
Construction of pBJ86 to pBJ89.
The expression plasmids
pBJ86 (
R73 Delta), pBJ87 (Delta), pBJ88 (Ogr), and pBJ89 (Pag) were
made as follows. The lacI-bearing plasmid pRG1
(8) was cleaved with BamHI; the cohesive ends were filled in by using Klenow fragment, and the product was cleaved with Eco57I. Activator gene fragments were prepared from
pBJ17f (11) (
R73 Delta), pBJ47 (12) (Delta),
pBJ49 (11) (Ogr), and pBJ72 (11) (Pag) by
cleavage with HindIII, followed by filling in with
Klenow fragment and cleavage with Eco57I. The appropriate fragments were purified by gel electrophoresis and ligated.
Construction of psid93.
In order to construct a promoter
fusion of Psid to lacZ, pB
93 and
pRS414 were digested with EcoRI and BamHI and the
293-bp fragment from pB
93, carrying Psid, was
ligated to the large fragment of pRS414.
Mutagenesis of site II of Psid.
The first
three nucleotides of site II from Psid were
mutated to the complementary sequence. This mutation was accomplished by replacing the TGT at
26 to
24 with ACA on a primer and
amplifying pB
93 by PCR (Fig. 1). The mutagenic primer was
5'-TCGTGTTGTACACCGGTGT-3', which corresponds to
P4 coordinates 9525 to 9543 (the ACA in boldface is the altered
sequence). The primer for the opposite strand was the 20-mer T3
promoter from New England Biolabs. The PCR product was ligated and
cleaved with EcoNI and BamHI. The fragment
containing the mutant promoter was isolated and ligated to the large
EcoNI-to-BamHI fragment of pB
93. The PCR
product was ligated in case some circular templates had been copied
completely. If the circular templates had been copied, then ligation
would make the product more stable after subsequent cleavage with
restriction enzymes. The ligation step may not be necessary for
success. The presence of the ACA mutation and the absence of other
mutations were ascertained by sequence analysis. The plasmid containing
the mutation, pcr1-3, was digested with EcoRI and
BamHI, and the fragment containing the mutation was ligated
to pRS414 digested with EcoRI and BamHI. This
plasmid is termed psidcr. The "cr" denotes complementary replacement.
Construction of bacteria with Psid and
mutant Psid fused to lacZ in the
host chromosome.
The wild-type and mutant
Psid promoters were introduced into a
phage
carrying lacZYA (
RS45) by recombination in vivo, as
described by Simons et al. (22), with psid93 as the source
of Psid and psidcr as the source of mutant
Psid. These phages were called
RS45sid and
RS45sidmut, respectively. E. coli C-2420 (12)
was lysogenized with these phages to give C-2420(
sidwt) and
C-2420(
sidmut), respectively.
Construction of P4 with mutant Psid. In order to facilitate passage of mutated Psid into P4 phage, Christina Wang cloned the large P4 BamHI fragment (nucleotides [nt] 4264 to 10659) into pUC19 (28) cleaved with BamHI. Plasmid pcr1-3 was cleaved with EcoNI (nt 9499) and BseI (nt 9589), and the 90-bp fragment containing mutant Psid was ligated to pCW1 cleaved with the same enzymes. The resulting plasmid, pCW4, was cleaved with EcoNI and ApaLI (nt 10653), and the 1,153-bp fragment carrying the mutated sid promoter was ligated to the large fragment of the P4 wild type cleaved with EcoNI and ApaLI. The phage is called P4 sid mut.
Purification of proteins. Maltose-binding protein (MBP)-P4 Delta mixed with Delta and MBP-Pag mixed with Pag were purified as described by Julien and Calendar (12, 13).
Gel shift analysis of wild-type and mutant promoters with
Delta.
Gel shift analyses were conducted as described by Julien
and Calendar (12), except that they were conducted with P4
Delta that had the MBP fusion cleaved from it. The
Psid fragment (nt
93 to +200) was made from
pB
93 or pcr1-3 by digestion with EcoRI and
BamHI. The binding reaction was performed in 15 µl
containing 25 mM Tris-HCl (pH 8.0), 14% glycerol, 133 mM NaCl, 20 µM
EDTA, 1 mM
-mercaptoethanol, and 0.133 µg of poly(dI-dC) per µl.
Approximately 50 fmol of 32P-labeled
Psid fragment and 12 pmol of Delta or Pag were used in each binding reaction mixture.
Factor Xa cleavage. The cleavage of MBP from Delta was carried out according to the suggestions of the manufacturer (New England Biolabs) except that the cleavage buffer was 20 mM Tris-HCl (pH 8.0)-250 mM NaCl-2 mM CaCl2-10% glycerol. One microgram of Factor Xa was added to buffer with 25 µg of MBP-Delta, and the reaction mixture was incubated at room temperature for 5 h. The cleavage reaction was more than 80% complete as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
DNase I footprint analysis. Increasing amounts of Delta were footprinted on sid wild-type and mutant promoters as described in the work of Julien and Calendar (12). This procedure used the Delta-MBP-Delta mixture; titration was begun at 4 pmol, and then the amount of protein used in each subsequent reaction mixture was doubled. A constant amount (100 fmol) of 32P-labeled Psid was used in each 20-µl reaction mixture. The Psid fragments were generated as described above for the gel shift.
-Galactosidase synthesis dependent upon induction of
activators from plasmids.
C-2420(
sidwt) and C-2420(
sidmut)
were transformed with either pBJ86, pBJ87, pBJ88, or pBJ89 (producing
R73 Delta, P4 Delta, Ogr, or Pag, respectively). Each strain was
inoculated into 15 ml of Luria-Bertani broth with 30 µg of kanamycin
per ml, and the cultures were grown at 37°C to an
A600 between 0.150 and 0.200. IPTG (1 mM;
isopropyl-
-D-thiogalactopyranoside) was added to each
culture, and after one more hour of growth, the cultures were placed on
ice and samples were removed and assayed for
-galactosidase activity
in quadruplicate according to the method of Miller (19).
-Galactosidase synthesis dependent upon P4 infection.
C-2420(
sidwt) and C-2420(
sidmut) were grown in 15 ml of
Luria-Bertani broth at 37°C. When the A600
reached 0.2, P4, P4 vir1, or P4 vir1
ins1 was
added at a multiplicity of infection of 10. Cultures were returned to
37°C, and samples were taken at 0, 20, 40, 60, and 120 min
postinfection and placed on ice. Each sample was then assayed for
-galactosidase activity in quadruplicate (19).
Competition gel shifts. To conduct titrating gel shifts of Delta or Pag on the two different sites from Psid, we used 32P-labeled oligonucleotides. For site I the oligonucleotides used were 5'-AGGATGAGTCTCCTGTGTCAGGGCTGGCACATCTGCAATG-3' (oligonucleotide 1) and 5'-CATTGCAGATGTGCCAGCCCTGACACAGGAGACTCATCCT-3' (oligonucleotide 2), and for site II the oligonucleotides used were 5'-GCGTCGTGTTGTTGTCCGGTGTACGTCACAATTTTCTTAA-3' (oligonucleotide 3) and 5'-TTAAGAAAATTGTGACGTACACCGGACAACAACACGACGC-3' (oligonucleotide 4). The consensus nucleotide sequences are underlined.
Oligonucleotides 1 and 3 were end labeled with [
-32P]ATP and T4 polynucleotide kinase, according to
the suggestions of the manufacturer (New England Biolabs). Site I
oligonucleotides were then annealed with 300 ng of the labeled
oligonucleotide 1 and 500 ng of oligonucleotide 2, contained in 250 mM
NaCl-100 mM Tris-HCl (pH 7.6)-100 mM MgCl-5 mM dithiothreitol. The
reaction mixture was incubated at 93°C for 3 min and then allowed to
slowly cool to room temperature. Site II oligonucleotides were treated
in the same way. To make unlabeled specific competitor DNA, unlabeled oligonucleotides were annealed.
Using 1.33 nM (approximately 30,000 cpm) site I or site II and a
constant amount of protein (93 µM for MBP-Delta plus Delta and 120 µM for MBP-Pag plus Pag), we titrated unlabeled site I. The nucleic
acids were added before the protein. Using the same amount of substrate
(1.33 nM), we also titrated unlabeled site II. The concentrations of
specific competitor (cold DNA) used started at 4× and went as high as
256× (competitor/substrate). The buffer and nonspecific competitor
used were as described above.
To measure the effect of the competitor, we measured the amount of DNA
in the shifted band by phosphorimager analysis. That amount was then
expressed as the fraction of the amount of DNA that was shifted when no
specific competitor was used. The adjusted amounts of shifted DNA were
then graphed against the amounts of specific competitor used.
| |
RESULTS |
|---|
|
|
|---|
Activator binding properties of mutated site II.
To
investigate the role of the binding site (site II) centered at
18 of
Psid, we used site-directed mutagenesis to
change nt
24 to
26 from TGT to ACA (Fig. 1). Sequence analysis confirmed the presence of the desired mutation and the absence of other
mutations.
|
|
In vivo activities of wild-type and mutant
Psid in the presence of helper and satellite
phage activators.
Since our site II mutant promoter did not bind
activators, we were in a position to test whether binding of site II by
activators affects regulation of transcription from
Psid. In order to control the promoter copy
number, we placed the wild-type and mutant Psid
promoters, fused to lacZ, in the E. coli chromosome. Wild-type and mutant Psid were
crossed into
phage, and lysogenic strains were constructed as
described in Materials and Methods. The lysogenic strains are
called C-2420(
sidwt) and C-2420(
sidmut). In order to test
activation of transcription from these promoters, we introduced
plasmids that express P4 Delta,
R73 Delta, PSP3 Pag, or P2 Ogr under
control of lacI. Induction of these activators with IPTG
showed that both Deltas stimulated the mutant promoter 10-fold better
than they stimulated wild-type Psid (Fig.
4). This result indicates that the Deltas repress transcription by binding to site II. In contrast, both of the
helper phage activators, Ogr and Pag, gave similar levels of
transcriptional activation for wild-type and mutant promoters.
|
sidwt) and C-2420(
sidmut).
Figure 5A shows that infection by P4
vir1 phage causes the chromosomal mutant
Psid to be activated 15-fold better than
wild-type Psid. When infection was carried out
with a P4 Delta null mutant,
-galactosidase synthesis was not
increased over the level seen in uninfected cells (Fig. 5B), confirming
that Delta is responsible for the observed activation. We also used wild-type P4 as a source for Delta and determined the difference in
levels of activation between the two promoters. In this case, basal
transcription of the wild-type promoter was reduced and the mutant
promoter was 30-fold more active than the wild type (Fig. 5C). These
results corroborate the data from the Delta overexpression experiment
(Fig. 4) and also indicate a true biological function for the
repression at site II on Psid. We attempted to perform a similar analysis using infection with the P2 wild type, but
such infection did not cause any increase in the synthesis of
-galactosidase. P2 inhibits the growth of infected E. coli, whereas P4 does not, so P2 may prevent the expression of
chromosomal genes.
|
Competition gel shift analysis. We hypothesized that the difference between the levels of activation of Psid by Delta and Pag was due to their respective affinities for site II. We suspected that Delta represses transcription of Psid because it binds better to site II than to the activating site (site I). To test this model, we determined the relative affinities of Pag and Delta for the two different sites in Psid. We conducted gel mobility shift assays using 32P-labeled site I and site II and various amounts of either unlabeled site I or unlabeled site II as specific competitors. We measured the amount of shifted DNA by phosphorimager analysis and plotted the normalized values against the competitor/substrate ratios used. Figure 6 shows the result from one experiment in which Delta was used as the DNA-binding protein. For the results shown in Fig. 6A, we used unlabeled site I as the competitor for labeled site I or site II. Unlabeled site I competes half of the labeled site I out of the shifted band at a competitor/substrate ratio of 32. A competitor/substrate ratio of 256 is needed for unlabeled site I to compete half of the labeled site II from the shifted band. Thus, site II appears to bind Delta eightfold better than does site I. For the results shown in Fig. 6B, we used unlabeled site II as the competitor. Unlabeled site II effectively competes Delta away from labeled site I. An eightfold-lower amount of unlabeled site II, relative to that of unlabeled site I, was needed for removal of half of labeled site I from the shifted band. These results show that Delta binds approximately eightfold better to site II than to site I.
|
|
The effect of our site II mutation on phage growth. In order to test the effect of our site II mutation on the P4 life cycle, we passaged our Psid site II mutation into wild-type P4 phage. This mutant phage (P4 sid mut) made tiny plaques, and we were unable to grow a high-titer stock. Thus, repression at site II by Delta appears to be important for proper regulation of gene expression, even during P4 lytic growth in the presence of a helper prophage.
| |
DISCUSSION |
|---|
|
|
|---|
We have studied the role of an activator binding site II in the
sid promoter. We mutated three nucleotides in the upstream end of the consensus sequence and demonstrated that neither the satellite phage activator, P4 Delta, nor the helper phage activator, Pag, could bind to this altered site II in vitro. We also studied the
expression of wild-type and mutant promoters after fusing them to
lacZ and inserting them into the host chromosome. Wild-type Psid was activated by P4 Delta,
R73 Delta,
and two helper phage activators, Ogr and Pag, supplied from plasmids.
The levels of activation were all within the same range, although Pag
worked better than Ogr or either of the Deltas. The mutant
Psid was activated approximately 10-fold better
by the P4 and
R73 Deltas than by Ogr or Pag. When Delta was supplied
by P4 infection, it also worked much better on the mutant
Psid than on the wild-type promoter. Thus, the
binding of Delta to site II appears to repress transcriptional
activation by Delta. In contrast, the absence of site II does not
greatly affect activation by Ogr or Pag. Repression of transcription by
Delta at site II helps to keep Psid from being
overexpressed in the absence of helper phage, which prevents wasteful
expression of the P4 capsid synthesis proteins Sid and Psu (whose genes
are transcribed from Psid) and of Delta. None of
these gene products are needed until helper phage infects the same
cell.
We have also shown that Delta binds eightfold better to site II than to site I but that Pag binds equally well to both. This finding suggests that at least part of the difference in levels of transcriptional activation is due to the relative affinities of the activators for the two sites. An additional reason for the differences in specificities of activators for Psid might be the nature of the protein-DNA complexes formed at site II. Delta bound to site II might contact and inhibit RNA polymerase, while Pag and Ogr bound to site II might contact and inhibit RNA polymerase, while Pag and Ogr bound to site II might have no contact with the transcribing enzyme.
When P4 produces progeny in the presence of a helper phage,
transcription from Psid occurs sooner and
reaches a higher level (3). This effect is due to the helper
phage activator, which causes transcription of
Psid directly. However, the
gene is in the
transcription unit controlled by Psid, so helper
phage activator also causes more expression of satellite phage
activator. The contributions of these two activators to increased
Psid expression have not been assessed
rigorously. One possibility is that the concentration of helper phage
activator is much higher than the concentration of satellite phage
activator. This higher concentration of helper phage activator might
cause site II to be occupied mostly by this activator, which does not repress transcription. Satellite phage activators appear to bind much
more tightly to site II than do helper phage activators, so the helper
phage activator would have to be present in much greater concentration
than satellite phage activator in order to overcome repression. Helper
phage activator might cause increased expression of
Psid from replicating, circular P4 DNA. Helper
phage activators are, in fact, more efficient than satellite phage
activators on plasmid-borne Psid
(13). This efficiency of helper phage activators on
Psid is not apparent when the promoter is in the
host chromosome (Fig. 4). The high level of Psid
expression during P4 lytic infection might also be due to binding of
helper phage activator to one binding site and binding of satellite
phage activator to the other site. High-level Psid expression might also be due to formation
of heteromultimers between satellite and helper phage activators. Such
hypothetical heteromultimers might bind site I and activate
transcription unusually well, and they might repress transcription
poorly at site II.
We are unsure of the mechanism for repression and activation at Psid. Our current models for repression involve steric hindrance of RNA polymerase, as shown in Fig. 8. For the model in Fig. 8A, there is no Delta present and basal transcription should occur. This situation should occur early in P4 infection before Delta has been produced from Psid. For the model in Fig. 8B, after basal transcription has produced a certain amount of Delta, Delta binds to site II because it has the higher affinity of the two sites and represses transcription. This repressed state should be maintained until either a helper phage infects or activator is supplied from another source. For the model in Fig. 8C, an infecting helper phage has supplied either Pag or Ogr, which then binds site I. The activator now bound at site I can recruit RNA polymerase to the promoter, leading to the initiation of transcription, thereby overcoming the repressing effects of Delta bound at site II. This model does not explain why only Delta, of all the factors which bind at site II, represses transcription. This phenomenon may be explained by the observed affinities of Delta and Pag to the two different sites. Delta at low levels will bind preferentially to site II, resulting in repression of transcription. When a certain threshold level of Delta is reached, then the additional Delta binds to site I and activates transcription. Pag, however, has equal affinities for both sites and may therefore either bind to site I, and activate transcription, or bind to site II, and repress transcription, with equal probabilities. Note that in the normal in vivo case, a basal level of Delta would be present and bound at site II, leading to preferential binding of Pag to site I and thereby causing activation of the sid promoter. In all of these cases, binding of a factor, Pag, Ogr, or Delta, to site I leads to the recruitment of RNA polymerase to the promoter region. The transcribing enzyme can now, with the aid of one of the transcriptional activators, replace the repressive factor bound at the initiation site. Steric hindrance, however, may not provide the correct explanation for repression by binding of Delta at site II. Perhaps upon binding to the separate sites, Delta undergoes different conformational changes, becoming appropriate for either activating or repressing transcription. The conformational changes leading to the repression of transcription would be specific to Delta and not the helper phage activators, which do not need this down regulation. Therefore, only Delta would repress transcription when it was bound at site II. Indeed, the concept of alternate DNA-binding sites differentially affecting the conformation of the same bound protein is very intriguing but not uncommon. Many examples of this allosteric effect have been recently reviewed by Lefstin and Yamamoto (16). Experiments aimed at differentiating between these two hypotheses are under way in our laboratory.
|
To summarize, we have shown that P4 and
R73 Deltas repress
transcription when site II is present but that Ogr and Pag do not. In
addition, we have shown that at least part of that difference is due to
differential levels of binding to the two sites in
Psid.
The models in Fig. 8 imply that only P2 Ogr and P4 Delta control the expression of Psid. We tested this proposition, at the suggestion of Erich Six, by using a bacterial strain that is lysogenic for P2 carrying a deletion of P2 ogr. We infected this strain with P4 and measured transcription from Psid using primer extension. The removal of P2 Ogr from the cell did not greatly reduce Psid transcription, and the stimulation of Psid transcription was very marked, when compared to that observed in a nonlysogenic strain. Thus, we plan to determine which P2 gene, in addition to ogr, causes Psid transcription.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by research grant AI-08722 from the National Institute of Allergy and Infectious Diseases.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular and Cell Biology, 401 Barker Hall, University of California, Berkeley, CA 94720-3202. Phone: (510) 642-5951. Fax: (510) 643-5035. E-mail: rishard{at}socrates.berkeley.edu.
Present address: Kosan Biosciences, Burlingame, CA 94010.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Calendar, R., E. Ljungquist, G. Dehò, D. C. Usher, R. Goldstein, P. Youderian, G. Sironi, and E. W. Six. 1981. Lysogenization by satellite phage P4. Virology 113:20-38[Medline]. |
| 2. | Choy, H., and S. Adhya. 1996. Negative control, p. 1287-1299. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Washington, D.C. |
| 3. | Dale, E., G. Christie, and R. Calendar. 1986. Organization and expression of the satellite bacteriophage P4 late gene cluster. J. Mol. Biol. 192:793-803[Medline]. |
| 4. | Dehò, G., D. Ghisotti, P. Alano, S. Zangrossi, M. G. Borrello, and G. Sironi. 1984. Plasmid mode of propagation of the genetic element. J. Mol. Biol. 178:191-207[Medline]. |
| 5. | Diana, C., G. Dehò, J. Geisselsoder, L. Tinelli, and R. Goldstein. 1978. Viral interference at the level of capsid size determination by satellite phage P4. J. Mol. Biol. 126:433-445[Medline]. |
| 6. |
Goldstein, R.,
J. Sedivy, and E. Ljungquist.
1982.
Propagation of satellite P4 as a plasmid.
Proc. Natl. Acad. Sci. USA
79:515-519 |
| 7. | Gralla, J., and J. Collado-Vides. 1996. Organization and function of transcriptional regulatory elements, p. 1232-1245. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. D. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Washington, D.C. |
| 8. |
Griffin, T. J., IV, and R. Kolodner.
1990.
Purification and preliminary characterization of the Escherichia coli K-12 RecF protein.
J. Bacteriol.
172:6291-6299 |
| 9. |
Halling, C., and R. Calendar.
1990.
Bacteriophage P2 ogr and P4 genes act independently and are essential for P4 multiplication.
J. Bacteriol.
172:3549-3558 |
| 10. |
Inouye, S.,
M. Sunshine,
E. W. Six, and M. Inouye.
1991.
Retronphage R73: an E. coli phage that contains a retroelement and integrates into a tRNA gene.
Science
252:969-971 |
| 11. |
Julien, B.
1994.
Studies of transcriptional activators: bacteriophages P4 and R73 proteins and Pag from phage PSP3. Ph.D. thesis.
University of California, Berkeley.
|
| 12. |
Julien, B., and R. Calendar.
1995.
Purification and characterization of the bacteriophage P4 Delta protein.
J. Bacteriol.
177:3743-3751 |
| 13. |
Julien, B., and R. Calendar.
1996.
Bacteriophage PSP3 and R73 activator proteins: analysis of promoter specificities.
J. Bacteriol.
178:5668-5675 |
| 14. | Julien, B., D. Pountney, G. E. Christie, and R. Calendar. Mutational analysis of a satellite phage activator. Gene, in press. |
| 15. |
Lee, T.-C., and G. E. Christie.
1990.
Purification and properties of the bacteriophage P2 ogr gene product.
J. Biol. Chem.
265:7472-7477 |
| 16. | Lefstin, J. A., and K. R. Yamamoto. 1998. Allosteric effects of DNA on transcriptional regulators. Nature 392:885-888[Medline]. |
| 17. | Lindqvist, B. H., G. Dehò, and R. Calendar. 1993. Mechanisms of genome propagation and helper exploitation by satellite phage P4. Microbiol. Rev. 257:683-702. |
| 18. |
Liu, T.,
S. K. Renberg, and E. Haggård-Ljungquist.
1997.
Derepression of prophage P2 by satellite phage P4: cloning of the P4 gene and identification of its product.
J. Virol.
71:5402-5408.
|
| 19. | Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 20. | Ow, D. W., and F. M. Ausubel. 1980. Recombinant P4 bacteriophages propagate as viable lytic phages or as autonomous plasmids in Klebsiella pneumoniae. Mol. Gen. Genet. 180:165-175[Medline]. |
| 21. | Pountney, D., R. P. Tiwari, and J. B. Egan. 1997. Metal- and DNA-binding properties and mutational analysis of the transcription activating factor, B, of coliphage 186: a prokaryotic C4 zinc-finger protein. Protein Sci. 6:892-902[Abstract]. |
| 22. | Simons, R. W., F. Houman, and N. Kleckner. 1987. Improved single and multicopy lac-based cloning vectors for protein and operon fusions. Gene 53:95-96. |
| 23. | Six, E. W., and C. A. C. Klug. 1973. Bacteriophage P4, a satellite virus depending on a helper such as prophage P2. Virology 51:327-344[Medline]. |
| 24. | Six, E. W., and B. H. Lindqvist. 1978. Mutual derepression in the P2-P4 bacteriophage system. Virology 87:217-230[Medline]. |
| 25. | Six, E. W., M. G. Sunshine, J. Williams, E. Haggård-Ljungquist, and B. H. Lindqvist. 1991. Morphopoetic switch mutations of bacteriophage P2. Virology 182:34-46[Medline]. |
| 26. |
Sun, J.,
M. Inouye, and S. Inouye.
1991.
Association of a retroelement with a P4-like cryptic prophage (Retronphage R73) integrated into the selenocystyl tRNA gene of Escherichia coli.
J. Bacteriol.
173:4171-4181 |
| 27. |
Van Bokkelen, G. B.,
E. C. Dale,
C. Halling, and R. Calendar.
1991.
Mutational analysis of a bacteriophage P4 late promoter.
J. Bacteriol.
173:37-45 |
| 28. | Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |